Berberine inhibits the system xCT–GSH–GPX4 axis, reducing GSH and GPX4 levels, increasing lipid ROS, and suppressing metastasis in NPC models [26]. This evidence concerns the gene SLC7A11 and nasopharyngeal carcinoma.